<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240405061417N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-08-06</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of two types of offloading insoles on the balance of patients with diabetic foot ulcers</public_title>
      <acronym></acronym>
      <scientific_title>Comparision between puzzle insole and conventional four-layer insole with offloading rocker sole shoe on dynamic balance and spatio-temporal parameters of gait in patients with diabetic foot ulcers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/76333</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Randomization description: In this cross-over study, the sequence of interventions and experimental conditions will be randomly determined as follows: First, a list of all participants will be prepared. Then, a random number generation software will be utilized to determine the sequential order for each participant. For this purpose, randomization algorithms available in R software will be used. Each participant will be assigned a unique random number that specifies the order of interventions and experimental conditions. The process will involve assigning even numbers to one order and odd numbers to another.
The results of the random assignment will be documented in separate tables, and the final order for each participant will remain confidential, with no review by other researchers, to ensure fair and random allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Diabetic polyneuropathy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: offloading  shoes with a 20-degree rocker sole with a conventional four-layer insole. Rocker insole shoe is a type of footwear modification where the sole of the shoe is curved. Its purpose is to allow the body's center of mass to roll over the support surface. The conventional four-layer insole used in this research consists of an upper layer of plastazote with a hardness of A30 in contact with the foot, a polyethylene foam layer with a hardness of A40 as the second layer, a polyethylene foam layer with a hardness of A50 as the third layer, and a shear force reduction layer made of pron located underneath all the layers. Intervention 2: Intervention group:  offloading  shoes with a 20-degree rocker sole with a puzzle four-layer insole. Rocker insole shoe is a type of footwear modification where the sole of the shoe is curved. Its purpose is to allow the body's center of mass to roll over the support surface. The conventional four-layer insole used in this research consists of an upper layer of plastazote with a hardness of A30 in contact with the foot, a polyethylene foam layer with a hardness of A40 as the second layer, a polyethylene foam layer with a hardness of A50 as the third layer, and a shear force reduction layer made of pron located underneath all the layers. Intervention 3: Control group: The patient's own shoes, which are low top with flat insoles.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It will be decided according to the journal's policies or other ways of publication in the future and in consultation with the research team</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Akram Tadi Beni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Shah Nazari St., Maddkaran St., Mader Square, Mirdamad, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459 13487</zip>
        <telephone>+98 21 2640 5626</telephone>
        <email>tadibeni.a@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Hassan Saeedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Shah Nazari St., Maddkaran St., Mader Square, Mirdamad, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459 13487</zip>
        <telephone>+98 21 2222 2059</telephone>
        <email>hassan-saeedi@yahoo.co.uk</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diabetic patients with foot ulcers only due to neuropathy
The ulcer of the forefoot
The maximum size of the ulcer is 2x2 cmm
The age of patients should be between 40 and 60 years
Diabetic foot ulcer is shallow
No amputation  of fingers
Absence of disease due to imbalance such as Parkinson's, MS, vestibular disorders or similar cases
Not taking drugs that affect balance
Have no history of using the researched off-loading shoes</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The ulcer is on the foot or leg or in the hindfoot
The vascular ulcers or neurovascular  ulcers
The ulcer has involved the bone</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G63.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diabetic polyneuropathy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: offloading  shoes with a 20-degree rocker sole with a conventional four-layer insole. Rocker insole shoe is a type of footwear modification where the sole of the shoe is curved. Its purpose is to allow the body's center of mass to roll over the support surface. The conventional four-layer insole used in this research consists of an upper layer of plastazote with a hardness of A30 in contact with the foot, a polyethylene foam layer with a hardness of A40 as the second layer, a polyethylene foam layer with a hardness of A50 as the third layer, and a shear force reduction layer made of pron located underneath all the layers.</i_keyword>
      <i_keyword>Intervention group:  offloading  shoes with a 20-degree rocker sole with a puzzle four-layer insole. Rocker insole shoe is a type of footwear modification where the sole of the shoe is curved. Its purpose is to allow the body's center of mass to roll over the support surface. The conventional four-layer insole used in this research consists of an upper layer of plastazote with a hardness of A30 in contact with the foot, a polyethylene foam layer with a hardness of A40 as the second layer, a polyethylene foam layer with a hardness of A50 as the third layer, and a shear force reduction layer made of pron located underneath all the layers.</i_keyword>
      <i_keyword>Control group: The patient's own shoes, which are low top with flat insoles</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Step width: It means the distance between the line of progress of the left foot and the line of progress of the right foot. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Step legnth: The length measured parallel to the forward line of the body from the heel contact of one foot to the heel contact of the other foot. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Step time: The time interval between the heel contact  of one foot with the ground and the heel contact  of the opposite foot with the ground. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Stance time percentage :This phase starts when the foot is in contact with the ground and with the complete separation of the same foot from the groundIt ends. The stance phase constitutes approximately 60% of the walking phase. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>The time percentage of the midstance phase: in observation; This phase of walking starts with the separation of the toes of the opposite foot from the ground and continues until the heel of the progressive foot is in contact with the ground and accounts for 29 to 37% of walking. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>The number of steps per unit of time (cadence): is the frequency of steps. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Lateral shift of the center of pressure: indicating the movement direction of the center of pressure to the left and right. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Anterior-posterior shift of the center of pressure: the direction of movement of the center of pressure is anterior-posterior. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
      <prim_outcome>Standard deviation of the center of pressure: The standard deviation of the center of pressure is obtained by calculating the displacement of all steps. Timepoint: Along with the patient's own shoes. After wearing shoes with a 20 degree rocker sole with a conventional four-layer insole. After wearing shoes with a 20 degree rocker sole with a puzzle insole. Method of measurement: In this study will be measured  by Treadmill device for systematic analysis of walking and running, and will be calculated and recorded with T-FDM zebris software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-31</approval_date>
        <contact_name>Ethics committee of Iran University of  Medical Sciences</contact_name>
        <contact_address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Shah Nazari St., Maddkaran St., Mader Square, Mirdamad, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
